BACKGROUND AND PURPOSE: Advances in thrombolytic therapy, brain imaging, and
neurointerventional techniques provide new therapeutic options for acute stroke. Intra …

OBJECTIVE: To determine the feasibility of combined intravenous and intra-arterial
thrombolytic therapy for acute ischemic strokes and to evaluate its associated risks, using …

BACKGROUND AND PURPOSE: Since the approval of intravenous tissue plasminogen
activator for acute ischemic stroke, great interest has been generated in cerebral fibrinolysis …

Introduction The aim of our study was to evaluate the safety and efficacy of intra-arterial (IA)
thrombolysis using recombinant tissue plasminogen activator (rt-PA) in patients with acute …

Abstract Background and Objectives: Randomized trials have demonstrated the benefit of
intra-arterial thrombolysis (IAT) for treatment of acute ischemic stroke, if performed within 6 …

Background and Purpose—We sought to evaluate predictors of clinical outcome,
angiographic success, and adverse effects after intra-arterial administration of urokinase for …

Background and Purpose—The National Institutes of Health (NIH) estimates that stroke
costs now exceed $45 billion per year. Stroke is the third leading cause of death and one of …

Background In patients with ischemic stroke, endovascular treatment results in a higher rate
of recanalization of the affected cerebral artery than systemic intravenous thrombolytic …

Stroke is a common cause of death and disability in industrialized nations. Technical
advances and the increased availability of noninvasive brain imaging techniques have …

BACKGROUND AND PURPOSE: We reported an experience of intra-arterial thrombolysis
(IAT) study triaged by emergent MRI. METHODS: Patients were recruited if vascular …